Dimethylarginine Dimethylaminohydrolase Overexpression Ameliorates Atherosclerosis in Apolipoprotein E-Deficient Mice by Lowering Asymmetric Dimethylarginine
- 31 May 2010
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 176 (5), 2559-2570
- https://doi.org/10.2353/ajpath.2010.090614
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Role of Dimethylarginine Dimethylaminohydrolases in the Regulation of Endothelial Nitric Oxide ProductionOnline Journal of Public Health Informatics, 2009
- Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Overexpression of Dimethylarginine Dimethylaminohydrolase Inhibits Asymmetric Dimethylarginine–Induced Endothelial Dysfunction in the Cerebral CirculationStroke, 2008
- Role of Asymmetric Dimethylarginine in Vascular Injury in Transgenic Mice Overexpressing Dimethylarginie Dimethylaminohydrolase 2Circulation Research, 2007
- Effect of asymmetric dimethylarginine on atherogenesis and erythrocyte deformability in apolipoprotein E deficient miceLife Sciences, 2007
- Asymmetrical Dimethylarginine Independently Predicts Total and Cardiovascular Mortality in Individuals with Angiographic Coronary Artery Disease (The Ludwigshafen Risk and Cardiovascular Health Study)Clinical Chemistry, 2007
- The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout miceKidney International, 2005
- Rosuvastatin Decreases Caveolin-1 and Improves Nitric Oxide–Dependent Heart Rate and Blood Pressure Variability in Apolipoprotein E −/− Mice In VivoCirculation, 2003
- Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatmentJCI Insight, 2000
- Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein EScience, 1992